Martin Walther

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Molecularly Imprinted

Positron Emission Tomography

Top Venues

EJNMMI radiopharmacy and chemistry

Pharmaceuticals (Basel, Switzerland)

Inorganic chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Santiago Andrés Brühlmann, Martin Walther, Klaus Kopka, Martin Kreller
Production of the PET radionuclide 61 Cu via the 62 Ni(p,2n) 61 Cu nuclear reaction. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Santiago Andrés Brühlmann, Martin Walther, Magdalena Kerstin Blei, Constantin Mamat, Klaus Kopka, Robert Freudenberg, Martin Kreller
Scalability study on [ 133 La]LaCl 3 production with a focus on potential clinical applications. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Santiago Andrés Brühlmann, Martin Walther, Magdalena Kerstin Blei, Constantin Mamat, Klaus Kopka, Robert Freudenberg, Martin Kreller
Scalability study on [ 133 La]LaCl 3 production with a focus on potential clinical applications. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Santiago Andrés Brühlmann, Martin Walther, Magdalena Kerstin Blei, Constantin Mamat, Klaus Kopka, Robert Freudenberg, Martin Kreller
Scalability study on [ 133 La]LaCl 3 production with a focus on potential clinical applications. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Wiebke Sihver, Martin Walther, Martin Ullrich, Anne-Kathrin Nitt-Weber, Jenny Böhme, Falco Reissig, Magdalena Saager, Kristof Zarschler, Christin Neuber, Jörg Steinbach, Klaus Kopka, Hans-Jürgen Pietzsch, Robert Wodtke, Jens Pietzsch
Cyclohexanediamine Triazole (CHDT) Functionalization Enables Labeling of Target Molecules with Al 18 F/ 68 Ga/ 111 In. Bioconjugate chemistry (2024)
Santiago Andrés Brühlmann, Martin Walther, Klaus Kopka, Martin Kreller
Production of the PET radionuclide 61 Cu via the 62 Ni(p,2n) 61 Cu nuclear reaction. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Santiago Andrés Brühlmann, Martin Walther, Martin Kreller, Falco Reissig, Hans-Jürgen Pietzsch, Torsten Kniess, Klaus Kopka
Cyclotron-Based Production of 67 Cu for Radionuclide Theranostics via the 70 Zn(p,α) 67 Cu Reaction. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Ina Kopp, Patrick Cieslik, Karl Anger, Thomas Josephy, Lucca Neupert, Gunasekaran Velmurugan, Michael Gast, Hubert Wadepohl, Santiago Andrés Brühlmann, Martin Walther, Klaus Kopka, Michael Bachmann, Holger Stephan, Manja Kubeil, Peter Comba
Bispidine Chelators for Radiopharmaceutical Applications with Lanthanide, Actinide, and Main Group Metal Ions. Inorganic chemistry (2023)
Santiago Andrés Brühlmann, Martin Kreller, Hans-Jürgen Pietzsch, Klaus Kopka, Constantin Mamat, Martin Walther, Falco Reissig
Efficient Production of the PET Radionuclide 133 La for Theranostic Purposes in Targeted Alpha Therapy Using the 134 Ba(p,2n) 133 La Reaction. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Ian Moore F Gilpin, Martin Ullrich, Thomas Erik Wuensche, Kristof Zarschler, Ondřej Lebeda, Jens Pietzsch, Hans-Jürgen Pietzsch, Martin Walther
Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics. ChemMedChem 16 (17) (2021)